Longeveron Inc (LGVN)

07:41 AM

Longeveron Inc. Earnings Call: Growth and Challenges - TipRanks

07:41 AM

08:31 AM

Longeveron Inc (NASDAQ: LGVN) Declines -0.65%: This $22.55 million Stock Could Go Down -557.89% - Stocks Register

08:31 AM

08:16 AM

Longeveron Inc. (NASDAQ:LGVN) Q4 2024 Earnings Call Transcript - Insider Monkey

08:16 AM

04:14 AM

LGVN To Complete ELPIS II Enrollment By Q2, Time To Keep An Eye On NXGL, What's The Buzz At ACON? - RTTNews

04:14 AM

Mar 02, 2025

Earnings call transcript: Longeveron Q4 2024 sees revenue surge, stock gains - Investing.com Canada

Mar 02, 2025

Mar 02, 2025

Longeveron Full Year 2024 Earnings: Beats Expectations - Yahoo Finance

Mar 02, 2025

Feb 28, 2025

Longeveron Inc. Reports Strong 2024 Financial Growth - TipRanks

Feb 28, 2025

Feb 28, 2025

Longeveron® Announces Full-Year 2024 Financial Results and Provides Business Update - GlobeNewswire

Feb 28, 2025

Feb 28, 2025

Can Longeveron's 237% Revenue Surge and Advanced Clinical Trial Transform Pediatric Heart Treatment? - StockTitan

Feb 28, 2025

Feb 26, 2025

LONGEVERON Earnings Preview: Recent $LGVN Insider Trading, Hedge Fund Activity, and More - Nasdaq

Feb 26, 2025

Feb 23, 2025

Longeveron (LGVN) Expected to Announce Quarterly Earnings on Tuesday - Defense World

Feb 23, 2025

Feb 21, 2025

Longeveron® Announces World Health Organization Approval of “laro - The National Law Review

Feb 21, 2025

Feb 21, 2025

LGVNRLongeveron Latest Stock News & Market Updates - StockTitan

Feb 21, 2025

Feb 21, 2025

Longeveron® to Report Full Year 2024 Financial Results and Host Conference Call on February 28, 2025 - The Manila Times

Feb 21, 2025

Feb 21, 2025

Longeveron Inc. to Announce Full-Year 2024 Financial Results and Company Update on February 28, 2025 - Nasdaq

Feb 21, 2025

Feb 18, 2025

Longeveron Cellular Therapy Granted International Non-Proprietary Name -February 18, 2025 at 10:33 am EST - Marketscreener.com

Feb 18, 2025

Feb 18, 2025

Longeveron’s Lomecel receives WHO non-proprietary name approval as laromestroce - TipRanks

Feb 18, 2025

Feb 18, 2025

Longeveron® Announces World Health Organization Approval of - GlobeNewswire

Feb 18, 2025

Feb 18, 2025

Breakthrough Alzheimer's Treatment Gets Official WHO RecognitionMajor Milestone for Rare Disease Therapy - StockTitan

Feb 18, 2025

Feb 14, 2025

Longeveron to Present at the Emerging Growth Virtual Conference on February 19, 2025 - Marketscreener.com

Feb 14, 2025

Feb 14, 2025

Biotech Breakthrough: Longeveron Reveals Latest Regenerative Medicine Advances at Major Conference - StockTitan

Feb 14, 2025

Feb 05, 2025

Longeveron announces board member resignation - MSN

Feb 05, 2025

Jan 31, 2025

Longeveron announces board member resignation By Investing.com - Investing.com South Africa

Jan 31, 2025

Jan 30, 2025

Longeveron Board Member Neil Hare Resigns - TipRanks

Jan 30, 2025

Jan 14, 2025

Geode Capital Management LLC Acquires 97,953 Shares of Longeveron Inc. (NASDAQ:LGVN) - Defense World

Jan 14, 2025

Jan 05, 2025

State Street Corp Takes Position in Longeveron Inc. (NASDAQ:LGVN) - Defense World

Jan 05, 2025

Dec 31, 2024

Longeveron (NASDAQ:LGVN) Stock Price Up 1.1% – Here’s What Happened - Defense World

Dec 31, 2024

Dec 18, 2024

Longeveron to Present at Biotech Showcase 2025 - The Manila Times

Dec 18, 2024

Dec 18, 2024

Longeveron CEO to Present at Biotech Showcase 2025: Spotlight on Regenerative Medicine Breakthroughs - StockTitan

Dec 18, 2024

Dec 09, 2024

Longeveron (NASDAQ:LGVN) Earns Buy Rating from Analysts at Roth Mkm - Defense World

Dec 09, 2024

Dec 08, 2024

Longeveron (NASDAQ:LGVN) Upgraded at Roth Capital - Defense World

Dec 08, 2024

Dec 07, 2024

Longeveron initiated with a Buy at Roth MKM - Yahoo Finance

Dec 07, 2024

Dec 06, 2024

Roth MKM Initiates Coverage of Longeveron (LGVN) with Buy Recommendation - MSN

Dec 06, 2024

Dec 04, 2024

Longeveron director Baluch Khoso sells $2,588 in stock By Investing.com - Investing.com Canada

Dec 04, 2024

Dec 04, 2024

Longeveron director Baluch Khoso sells $2,588 in stock - Investing.com

Dec 04, 2024

Dec 02, 2024

Longeveron to Present at the Emerging Growth Virtual Conference on December 5, 2024 - Marketscreener.com

Dec 02, 2024

Nov 28, 2024

Longeveron FY2024 EPS Forecast Increased by HC Wainwright - Defense World

Nov 28, 2024

Nov 27, 2024

Longeveron (NASDAQ:LGVN) Earns “Buy” Rating from HC Wainwright - Defense World

Nov 27, 2024

Nov 25, 2024

H.C. Wainwright reiterates Buy on Longeveron stock, raises target by 25% on trial progress - Investing.com India

Nov 25, 2024

Nov 23, 2024

Longeveron Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 23, 2024

Nov 20, 2024

Longeveron stock opened 100% up on Wednesday: explore why - MSN

Nov 20, 2024

Nov 15, 2024

We're Keeping An Eye On Longeveron's (NASDAQ:LGVN) Cash Burn Rate - Yahoo Finance

Nov 15, 2024

Nov 15, 2024

ARMISTICE CAPITAL, LLC Acquires New Stake in Longeveron Inc - GuruFocus.com

Nov 15, 2024

Nov 14, 2024

The Escalator: Sanofi, Longeveron, Geron and more - MM+M Online

Nov 14, 2024

Nov 13, 2024

Earnings call: Longeveron Q3 2024 results show promise in regenerative medicine - Investing.com

Nov 13, 2024

Nov 13, 2024

Longeveron Inc. (NASDAQ:LGVN) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 13, 2024